Matteo Martino

Medicine & Life Sciences

1. Bipolar Disorder 100%
2. Duloxetine Hydrochloride 54%
3. Major Depressive Disorder 28%
4. Neurotransmitter Agents 24%
5. Depression 23%
6. Antidepressive Agents 21%
7. White Matter 20%
8. Diffusion Tensor Imaging 18%
9. Mental Disorders 15%
10. S 20098 15%
11. Raphe Nuclei 14%
12. Thalamus 14%
13. Substantia Nigra 13%
14. Brain 13%
15. Schizophrenia 13%
16. Cognitive Dysfunction 11%
17. Temperament 11%
18. Serotonin 11%
19. Obsessive-Compulsive Disorder 10%
20. Motor Cortex 10%
21. Dopamine 10%
22. Basal Ganglia 8%
23. Zonisamide 7%
24. Th1-Th2 Balance 7%
25. Chronic Progressive Multiple Sclerosis 6%
26. Psychopharmacology 6%
27. Treatment-Resistant Depressive Disorder 6%
28. Anisotropy 6%
29. Electroretinography 6%
30. Magnetic Resonance Imaging 6%
31. Bupropion 6%
32. Psychopathology 6%
33. Receptors, Serotonin, 5-HT3 6%
34. Therapeutics 6%
35. Serotonin Uptake Inhibitors 6%
36. beta-Endorphin 5%
37. Pharmaceutical Preparations 5%
38. Opioid Analgesics 5%
39. mu Opioid Receptor 5%
40. Tinnitus 5%
41. Immunomodulation 5%
42. Treatment Adherence and Compliance 5%
43. Opioid Receptors 5%
44. Nerve Growth Factor 5%
45. Corpus Callosum 5%
46. 1-(2-(dodecyloxy)ethyl)pyrrolidine hydrochloride 5%
47. Brain-Derived Neurotrophic Factor 5%
48. Norepinephrine 5%